EARNINGS: Safestay annual loss widens; Wynnstay ups interim dividend
(Alliance News) - The following is a round-up of earnings of London-listed companies, issued on Monday and not separately reported by Alliance News: Read More
| Price | 0.35p on 09-07-2026 at 06:51:25 |
|---|---|
| Change | 0.00p 0% |
| Buy | 0.40p |
| Sell | 0.30p |
| Last Trade: | Sell 323,711.00 at 0.31p |
| Day's Volume: | 0 |
| Last Close: | 0.35p |
| Open: | 0.00p |
| ISIN: | GB00BM8HZD43 |
| Day's Range | 0.00p - 0.00p |
| 52wk Range: | 0.325p - 1.125p |
| Market Capitalisation: | £10.46m |
| VWAP: | 0.00p |
| Shares in Issue: | 2.99b |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
Verici Dx (VRCI) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Sell* | 323,711 | 0.31p | Ordinary |
16:12:49 - 08-Jul-26 |
| Sell* | 953,493 | 0.315p | Ordinary |
16:11:45 - 08-Jul-26 |
| Sell* | 634,921 | 0.315p | Ordinary |
16:10:56 - 08-Jul-26 |
| Sell* | 318,572 | 0.315p | Ordinary |
16:09:17 - 08-Jul-26 |
| Buy* | 200,000 | 0.343p | Ordinary |
15:53:50 - 08-Jul-26 |
| Sell* | 2 | 0.30p | Ordinary |
15:53:46 - 08-Jul-26 |
| Buy* | 1 | 0.35p | Ordinary |
15:53:40 - 08-Jul-26 |
| Buy* | 300,000 | 0.3448p | Ordinary |
15:37:18 - 08-Jul-26 |
| Buy* | 289,153 | 0.3448p | Ordinary |
15:27:11 - 08-Jul-26 |
| Buy* | 1,414 | 0.35p | SI Trade |
15:22:50 - 08-Jul-26 |
Verici Dx (VRCI) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 6th Jul 2026 7:00 am | RNS-R | Investor presentation |
| 1st Jul 2026 11:22 am | RNS | Holding(s) in Company |
| 29th Jun 2026 7:00 am | RNS | Final results for the year ended 31 December 2025 |
| 25th Jun 2026 4:08 pm | RNS | Holding(s) in Company |
| 24th Jun 2026 5:24 pm | RNS | Holding(s) in Company |
| 24th Jun 2026 4:34 pm | RNS | Holding(s) in Company |
| 24th Jun 2026 12:37 pm | RNS | Holding(s) in Company |
| 24th Jun 2026 11:13 am | RNS | Holding(s) in Company |
| 24th Jun 2026 9:06 am | RNS | Holding(s) in Company |
| 24th Jun 2026 7:00 am | RNS | New York State clinical lab certification received |